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ABSTRACT Exceptions to the Meyer-Overton rule are commonly cited as evidence against indirect, membrane-mediated
mechanisms of general anesthesia. However, another interpretation is possible within the context of an indirect mechanism
in which solubilization of an anesthetic in the membrane causes a redistribution of lateral pressures in the membrane, which
in turn shifts the conformational equilibrium of membrane proteins such as ligand-gated ion channels. It is suggested that
compounds of different stiffness and interfacial activity have different intrinsic potencies, i.e., they cause widely different
redistributions of the pressure profile (and thus different effects on protein conformational equilibria) per unit concentration
of the compound in the membrane. Calculations incorporating the greater stiffness of perfluoromethylenic chains and the
large interfacial attraction of hydroxyl groups predict the higher intrinsic potency of short alkanols than alkanes, the cutoffs
in potency of alkanes and alkanols and the much shorter cutoffs for their perfluorinated analogues. Both effects, increased
stiffness and interfacial activity, are present in unsaturated hydrocarbon solutes, and the intrinsic potencies are predicted to
depend on the magnitude of both effects and on the number and locations of multiple bonds within the molecule. Most
importantly, the intrinsic potencies of polymeric alkanols with regularly spaced hydroxyl groups are predicted to rise with
increasing chain length, without cutoff; such molecules should serve to distinguish unambiguously between indirect mech-
anisms and direct binding mechanisms of anesthesia.
INTRODUCTION
The potency of a general anesthetic is usually described by
its concentration in the phase in which it is administered
(gas or aqueous); the lower the concentration, the higher the
potency. A century ago, Overton (1901, translation 1990)
and Meyer (1899, 1901) independently discovered that for
many compounds the anesthetic potency (as measured by
the inverse of its aqueous phase molar concentration c*w) is
nearly linearly correlated with its oil/water partition coeffi-
cient Ko/w  co/cw, where co and cw represent relative
equilibrium concentrations of the anesthetic in the oil and
water phases, respectively. There is a thermodynamically
equivalent correlation between the oil/gas partition coeffi-
cient Ko/g co/cg of the anesthetic and its potency measured
by the inverse of its gas phase concentration c*g. The corre-
lation is remarkably good over a wide range of anesthetics,
using olive oil as the oil phase, as in the original work of
Meyer and Overton, and improves considerably in both the
quality of the correlation and the increased range of anes-
thetics if bulk octanol (Franks and Lieb, 1978) or a fully
hydrated fluid lipid bilayer (Janoff et al., 1981; Taheri et al.,
1991; Vaes et al., 1997; Meijer et al., 1999) is used as the
“oil” phase. To the extent that anesthetics obey this Meyer-
Overton correlation, the anesthetic concentration in the oil
phase, c*o  Ko/g c*g  Ko/w c*w, will be constant. If the oil
is a lipid bilayer, then c*o represents the molar concentration
of anesthetic in the bilayer, which indicates that anesthetic
potency is determined by the bilayer concentration of anes-
thetic, independent of its molecular identity. As was real-
ized long ago, this correlation strongly suggests an indirect
mechanism of anesthesia in which the activity of the mem-
brane protein(s) responsible for anesthesia is modulated by
variations in some crucial property of the membrane, which
is perturbed by the incorporation of an anesthetic solute to
a degree determined by its concentration in the bilayer.
In the context of an indirect mechanism, it is natural to
define an intrinsic potency as inversely proportional to the
membrane concentration of anesthetic, which would be
expected to vary little among anesthetics that closely follow
the Meyer-Overton rule. The apparent potency for such
compounds, inversely proportional to c*g (or c*w) may vary
widely, but Ko/g (or Ko/w) varies in inverse proportion so as
to keep the intrinsic potency roughly constant. The concen-
trations in lipid bilayers of many such anesthetics can be
determined from measured partial pressures or aqueous
concentrations and bilayer/water or bilayer/gas partition co-
efficients (Janoff et al., 1981; Taheri et al., 1991; Vaes et al.,
1997; Meijer et al., 1999). For pure lipid bilayers such as
dimyristoylphosphatidylcholine (DMPC), the clinically rel-
evant mole fraction of anesthetics in the lipid bilayer is
roughly x*  0.02 to 0.05 for anesthetics that obey the
Meyer-Overton rule (Janoff and Miller, 1982), although the
value decreases considerably if cholesterol is incorporated
in the bilayer (Miller, 1985; Franks and Lieb, 1986).
Clearly, the “typical” value of x* will depend on the choice
of anesthetic endpoint, the molecular composition of the
bilayer, etc., so this range of values of x* provides only a
rough estimate.
It is not surprising that the exceptions to this rule have
received much attention. For example, short chain 1-al-
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kanols have somewhat greater intrinsic potency than the
rule would predict (Fang et al., 1997). However, as their
chain length n increases, the intrinsic potency decreases (x*
increases) up to n  12, beyond which the alkanols have no
potency, i.e., the homologous series exhibits a cutoff (Prin-
gle et al., 1981; Franks and Lieb, 1986). Within this series,
Ko/g (or Ko/w) increases very rapidly with increasing chain
length (by a multiplicative factor of approximately 3 per
added methylene group.) Thus, the gradual decrease in
intrinsic potency occurs simultaneously with an increase in
apparent potency for this series, resulting in a cutoff that is
abrupt only for the apparent potency. This behavior is
observed for other homologous series. For example, for
,-alkanediols, a decrease in intrinsic potency occurs with
increasing chain length, but less rapidly than for alkanols
(Moss et al., 1991). Alkanes, which are much less potent
than the rule would predict even when short, further lose
intrinsic potency with increasing chain length, with a cutoff
at shorter length than for alkanols (Liu et al., 1993, 1994b).
Perfluorinated alkanes and perfluoroalkyl methanols of the
form Cn1F2n1CH2OH also exhibit a cutoff, but at even
shorter chain lengths (Pringle et al., 1981; Liu et al., 1994a;
Eger et al., 1994, 1999a).
Deviations from the Meyer-Overton rule can be inter-
preted in various ways. Most commonly, they are presented
as evidence that the fundamental premise of an indirect
mechanism is incorrect, and that anesthetics therefore are
more likely to act by binding directly to protein sites (Kra-
sowski and Harrison, 1999; Franks and Lieb, 1994), al-
though the direct experimental evidence for the location of
such sites on ligand-gated ion channels is sparse (Eckenhoff
and Johansson, 1997; Pratt et al., 2000; Mascia et al., 2000).
However, there are other interpretations. The most obvious
one is that an anesthetic mechanism may indeed be mem-
brane-mediated, but those solutes that disobey the rule have
different intrinsic potencies. In other words, the effect of
solutes on that property of the bilayer that alters protein
conformational equilibria depends not only on membrane
concentration but also on the identity of the solute. What
property of the membrane is altered upon incorporation of
anesthetics but not by nonanesthetics, is mechanistically
linked to protein conformational equilibria, and causes sig-
nificant shifts in protein equilibria at clinically relevant
anesthetic concentrations?
Various bilayer properties have been considered as a
possible link between changes in bilayer composition and
resulting modulations in the activity of key intrinsic mem-
brane proteins. As discussed previously (Cantor, 1999a,c),
membrane characteristics such as hydrophobic thickness,
dipole potential, fluidity, curvature elastic properties, prox-
imity to phase transitions, and the degree of lateral micro-
heterogeneity all vary with membrane composition and
have thus been suggested as having a potentially strong
influence on membrane protein function (Brown, 1997;
deKruijff, 1997; Epand, 1996; Gruner, 1991; Hui, 1997;
Lundbaek and Andersen, 1999; Morein et al., 1996; Mourit-
sen and Jørgensen, 1997; Mouritsen and Bloom, 1993;
Nielsen et al., 1998; North and Cafiso, 1997; Qin et al.,
1995). However, it has been noted (Franks and Lieb, 1994)
that the changes in most of these properties (thickness, order
parameter profiles, phase transition temperatures) are very
small at clinically relevant concentrations of anesthetics and
can be produced in the absence of anesthetic through slight
changes in other variables, such as temperature. [It is im-
portant to note that the increase in gas-phase, but not aque-
ous-phase, apparent potencies with decreasing temperature
of most inhalation anesthetics is accompanied by an in-
crease in oil/gas partition coefficients (Franks and Lieb,
1982) such that the clinically relevant membrane concen-
tration x* does not depend sensitively on temperature. Thus,
a plausible indirect mechanism would require a bilayer
property that is strongly affected by anesthetics but only
weakly by temperature changes.] Were there no bilayer
properties both sensitive to incorporation of solutes and
capable of influencing protein equilibria, it could be con-
cluded that such indirect mechanisms are likely to play at
most a minor role in the modulation of protein activity. How-
ever, it has been suggested (Gruner, 1991; Seddon and Tem-
pler, 1995; Cantor, 1998, 1999a) that the distribution of lateral
stresses (i.e., the lateral pressure profile) in bilayers may be
such a property, because it is predicted (Cantor, 1998, 1999a)
to be strongly affected by incorporation of interfacially active
solutes as well as by altered lipid composition, but not by
small changes in temperature; more importantly, it is mech-
anistically linked to altered protein conformational equilibria.
A stringent test of an indirect mechanism involving the
lateral pressure profile is, then, to determine whether it
accurately predicts the known anomalies in the Meyer-
Overton correlation. So, in the present paper, statistical
thermodynamic calculations are used to predict the intrinsic
potencies and thus the existence of cutoffs among the series
of alkanes, alkanols, ,-alkanediols, and their stiffer per-
fluorinated counterparts, which can be compared to exper-
imental results, at least qualitatively. Predictions are also
reported for classes of molecules for which potencies have
not yet been measured. In particular, the intrinsic potency of
oligomeric alkanols (i.e., alkanols with regularly spaced
hydroxyl groups) is predicted to increase roughly linearly
with the number of repeat units in the oligomer, and thus
with chain length. Because it would appear difficult for such
increasingly large molecules to be accommodated in any
binding site (no matter how nonspecific), a measurement of
the potencies of such molecules would be expected to
distinguish unambiguously between indirect and direct
binding mechanisms of anesthesia.
THEORY
An indirect mechanism: the lateral
pressure profile
As discussed in detail elsewhere (Cantor, 1999a,b), a lipid
bilayer is characterized by very large lateral pressure den-
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sities p(z) distributed nonuniformly (i.e., varying with depth
z) in the hydrophobic interior, balanced largely by tensions
(negative pressures) at the aqueous interfaces (Israelachvili
et al., 1980; Seddon, 1990; Xiang and Anderson, 1994;
Seddon and Templer, 1995; Ben-Shaul, 1995; Harris and
Ben-Shaul, 1997; Venturoli and Smit, 1999; Lindahl and
Edholm, 2000). Transmembrane domains of proteins such
as ligand-gated ion channels are necessarily subjected to
these lateral pressures. A conformational transition of a
membrane protein such as the opening of an ion channel
results in a change in shape that will, in general, be char-
acterized by a lateral expansion or contraction that varies
with depth in the membrane, i.e., a nonuniform change in
protein cross-sectional area in the transmembrane domain
A(z). Because the bilayer exerts lateral pressures against
which the protein expands or contracts laterally, this tran-
sition involves mechanical work, the amount determined by
the depth dependence of the lateral pressure profile and of
the changes in protein cross-sectional area. A change in
membrane composition, such as the incorporation of hydro-
phobic or amphiphilic solutes, is predicted (Cantor, 1998,
1999a) to cause a significant depth-dependent redistribution
of these lateral pressures p(z), resulting in a shift in the
protein conformational equilibrium and thus in altered sen-
sitivity of the protein to its normal agonist.
Unfortunately, there exists little direct experimental in-
formation on the change in shape of the transmembrane
domains of postsynaptic ligand-gated ion channel proteins
that accompanies the conformational transition (channel
opening) relevant to their function. Still, there is consider-
able evidence (Popot and Engelman, 2000, and references
therein) suggesting that the transmembrane domains of
many intrinsic membrane proteins comprise bundles of pre-
dominantly -helical secondary structural units that span
the bilayer, and that for such bundles, the protein may
achieve its conformational change with a relatively small
expenditure of free energy through a cooperative reorienta-
tion of the transmembrane segments of the bundle, as has
been reported for the nicotinic acetylcholine receptor (Un-
win, 1993, 1995). In recent work (Cantor, 1999b), such
collective reorientations have been analyzed using simple
geometric models of collective tilts and rotations of bundles
of both kinked and cylindrical helices, and it is shown that
such conformational changes are particularly sensitive to
redistributions of membrane lateral pressures. More pre-
cisely, it is readily shown (Cantor, 1999b) that at this level
of approximation, the shifts in protein conformational equi-
libria depend predominantly on changes in the first and
second integral moments of the pressure distribution. For





where z  0 at the center of the bilayer and z  h and h
at the aqueous interfaces. In essence, P1 is a measure of a
shift in the center of the lateral stress distribution in each
leaflet of the bilayer away from (P1  0) or toward
(P1 	 0) the center of the bilayer. (The interpretation of
the second moment P2 is more complex, but since the
trends for P2 and P1 are predicted to be similar, only the
results for P1 are discussed below.) Using these geometric
models, the magnitude of P1 required to generate a sig-
nificant change in protein conformational equilibrium can
be estimated (Cantor, 1999b). For example, it is shown that
for a protein of radius 
20 Å that undergoes a small
tilt/rotation of order 5° to 10°, a shift in conformational
equilibrium by a factor of two would be predicted for P1
of order 0.02 (in units of kBT Å1), the direction of the
equilibrium shift determined by the sign of P1. If the mole
fraction of solute in the bilayer is denoted x, then the
intrinsic potency of an anesthetic can be defined as S 
P1/x. Taking x* 0.02 to 0.05 as a rough estimate (Janoff
and Miller, 1982) of the mole fraction of an anesthetic (one
that follows the Meyer-Overton correlation, as discussed
earlier) in the bilayer at its EC50 concentration (i.e., at c*w),
then S  0.5 kBT Å1 provides an order of magnitude
estimate of the intrinsic potency of anesthetics that obey the
Meyer-Overton rule. Those molecules with anomalously
low intrinsic potencies will have smaller values of S. Mol-
ecules predicted to have S  0 would be nonanesthetics in
the sense that they would not cause anesthesia at any mem-
brane concentration, and would be predicted to have no
effect on the anesthetic potency of standard anesthetics, as
measured through additivity studies. Those solutes pre-
dicted to have S 	 0 would have negative anesthetic po-
tency, in the sense that they would be predicted to decrease
the potency (i.e., increase the EC50 or MAC) of standard
anesthetics in additivity studies, the magnitude of the effect
increasing with the magnitude of S.
CALCULATION METHODOLOGY
Mean-field statistical thermodynamic theory is used to calculate the equi-
librium properties of the lipid bilayer system, using a modified lattice
model to describe the chain conformational contributions to the free
energy. Except as discussed below, the approach is essentially identical to
that used in recent work (Cantor, 1999a) to predict pressure profiles for
bilayers for a wide range of lipid and lipid/solute compositions. A summary
of the method and approximations is provided here; the interested reader
should refer to Cantor (1999a) and references therein for details. The power
of this kind of methodology for predicting structural and thermodynamic
properties has been shown for aggregates of surfactants in solution, and for
self-assembled or spread monolayer and bilayer films (Ben-Shaul, 1995;
Ben-Shaul and Gelbart, 1994; Leermakers and Lyklema, 1992; Wijmans et
al., 1994; Leermakers and Scheutjens, 1988; Cantor, 1995, 1996). As with
all models, it relies on assumptions and approximations that serve to make
the calculations tractable and result in interpretable predictions. The bilayer
is treated as two compact monolayers, in each of which the segments of the
acyl chains occupy space at constant bulk density, i.e., no free volume is
permitted. The distribution of chain segments is described using a lattice
model, in which a chain configuration is defined as occupying a particular
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set of contiguous lattice sites. As in previous work, the boundary between
the hydrophilic (head group) region and hydrophobic interior of the bilayer
is approximated by a sharp planar interface. For the lipids, the junction of
each acyl chain with its head group is constrained to reside on that plane,
so that, for example, the complexity of the glycerol/carbonyl linkage
between the phosphocholine head group and the acyl tails in phospholipids
is completely ignored, as is the considerable roughness present in the
interfacial region (Merz and Roux, 1996; Tielemann et al., 1997). Although
interfacial roughness could readily be incorporated into the model (Leer-
makers and Scheutjens, 1988), it would require assumptions about addi-
tional interaction energies that are not well known, so it is unlikely that any
additional predictive value would result. For purposes of describing hy-
drophobic solutes, the calculation of the conformational free energy has
been modified and extended in the present work to allow all possible
locations of the solute in the bilayer. For simplicity of calculation, neither
lipid nor solute chains are allowed to cross the bilayer midplane, i.e., there
is no interdigitation between monolayers. This restriction certainly causes
an increase in the fraction of bonds oriented horizontally near the midplane,
affecting the orientational ordering and the lateral pressure in that region.
However, for most biological membranes there is little interdigitation, so
this approximation is expected to be of minor importance.
The bilayer free energy contains both entropic and energetic contribu-
tions. The configurational entropy of the lipid and solute chains is calcu-
lated in mean-field approximation, incorporating bond-correlated excluded
volume of chain segments. Three contributions to the internal energy of the
bilayer are incorporated: segmental energies (including bending stiffness
and, as appropriate, a local attraction of selected segments for the aqueous
interface), interfacial tension, and head group interactions. At discrete
values of the lipid surface density (at which the membrane thickness is an
integer multiple of the size of a lattice site), the free energy is minimized
with respect to the probability distribution of chain conformations, subject
to the constraints of constant bulk density (one chain segment per lattice
site) within the hydrophobic core of the bilayer, from which the depth-
dependent pressures (and the total lateral pressure) are obtained. The
calculated free energy values are fit to a polynomial in the surface density,
the minimum of which determines the equilibrium surface density and the
lateral pressure profile.
For both lipid and solute molecules, the lattice statistical mechanical
approach provides the equilibrium probability distribution P(q) of chain
conformational states q, from which conformational averages such as the
spatial distribution of chain segments can be determined. For a solute of
chain length n, a conformational state q is defined by the set of sites
occupied by its n segments, each of which is defined by its depth z in the
membrane (as well as the spatial direction of its bonds to the adjacent
segments on the chain.) For a given solute conformation q, we let q(z)
represent the total number of segments of the solute at depth z in the lattice
(irrespective of the directional orientations of the bonds to adjacent seg-
ments on the chain.) On average, the number of solute segments at depth
z is given by (z) q P(q) q(z). Since each solute chain has n segments,
the spatial probability distribution of solute segments, i.e., the fraction of
solute segments found in a layer of lattice sites at depth z, is (z)  (z)/n.
Solute and lipid characteristics
Solute: chain stiffness
In unsubstituted, saturated alkanes, the hydrocarbon chain is semiflexible,
whereas for some substituted alkanes, and at sites of unsaturation (alkenes
and alkynes) the molecule can become considerably more rigid. In partic-
ular, for perfluorinated alkanes, the energetic cost for local bending of the
chain is considerably greater than for alkanes. Also, detailed calculations
(Smith et al., 1994) indicate that the distribution of conformational states of
perfluorinated alkanes is more complex than for alkanes. The effective
gauche/trans energy difference is roughly twice that of alkanes, with a large
additional energy cost for adjacent gauche conformers, resulting in a
reduction in the probability  of a chain bend by roughly a factor of three
compared to alkanes. In the lattice model used in the calculations, we thus
estimate [(CF2)x] 0.15, with [(CH2)x] flex 0.45 as in prior work
(Cantor, 1999a). For simplicity, these values are taken to be independent of
the substituents on the adjacent segments. Note that in chain molecules of
n segments, the stiffness is only defined for the n  2 interior segments,
i.e., at segments i  2, 3, . . . , n  1.
For the triple bonds in alkynes, the increase in rod-like stiffness at each
of the (interior) carbons is very high. In alkenes, both trans and cis isomers
are more rigid, but the backbone of the trans isomer is better modeled as
more extended than that of saturated alkanes (rod 	 flex), whereas cis
isomers are stiffly bent (bent  1). If the local rigidity at internal
segments i is denoted ri, with ri  s (rod-like, rod), f (semiflexible, flex),
or b (bent, bent) then the distribution of molecular rigidity along the solute
chain can be expressed as {r2, r3, . . . , rn1}. An unsaturated bond between
adjacent segments increases the stiffness at both segments, except if the
unsaturation involves terminal chain segments. Using six-segment solutes
as an example (for which calculated potencies are reported below) unsat-
urated chains with localized stiffness distribution {s, f, f, f}, would serve as
a crude model of 1-hexyne or 1-hexene, whereas {s, s, f, f} and {f, s, s, f}
would serve as models for 2-hexyne (or trans-2-hexene) and 3-hexyne (or
trans-3-hexene), respectively. The multiply unsaturated hexanes 1,3-
hexadiyne, 2,4-hexadiyne, 1,4-hexadiyne, and 1,5-hexadiyne (or more ap-
proximately, for the corresponding trans-dienes) would be represented as
{s, s, s, f}, {s, s, s, s}, {s, f, s, s}, and {s, f, f, s}, respectively, and
1,3,5-hexatriyne would be {s, s, s, s}. Of course, the conformational
flexibility f at an internal methylene group in, for example, 1,4-hexadiene
or 1,4-hexadiyne is not identical to a methylene group in hexane, but for
simplicity, only one value of the stiffness, flex  0.45, is used to describe
a saturated carbon in the calculations, regardless of its neighbors. Unfor-
tunately, a precise specification of the value of rod is difficult, so in the
present work results are reported for calculations using rod  0.15
(threefold lower probability of a chain bend compared to saturated alkane
chains, as used for perfluorination) as a likely representative value for both
alkynes and trans-alkenes.
Solute: interfacial activity of chain segments
Each segment of the solute can be characterized by an interfacial exchange
energy , i.e., the energy to exchange it from the membrane interior with
a segment of the lipid “solvent” (a CH2 group) at the aqueous interface.
Clearly, the interfacial attraction of a hydroxyl group is very strong ( 	
0, with   kBT), arising largely from its ability to donate a hydrogen
bond, whereas the exchange energy of a solute CH2 group is zero by
definition. There are smaller differences among CH2, CF2, CH3, and CF3
groups as well. Results of molecular dynamics simulations (Cui et al.,
1998) suggest a net interfacial attraction of CH3 groups, a much smaller
attraction of CF3 groups, but a positive interfacial exchange energy (ef-
fectively an interfacial repulsion) for CF2. For simplicity, and because
getting accurate numerical estimates of the strength of these interactions is
difficult, these differences in interfacial interactions are ignored in the
present work, as are the differences in exchange pairwise interaction
energies among CH2, CF2, CH3, and CF3 groups. However, they may well
underlie the marked differences in membrane distribution (North and
Cafiso, 1997) and anesthetic potencies (Koblin et al., 1994) among cy-
clobutanes of different degrees of fluorination.
In addition to causing increased stiffness, the presence of unsaturation
in hydrocarbon chains is likely to result in a greater attraction to the
aqueous interface (as compared to saturated bonds between adjacent meth-
ylene groups), characterized by an interfacial attraction per unsaturated
segment u 	 0. This net attraction is presumably larger for segments
involved in triple bonds than in double bonds, and would be expected to
increase in magnitude for molecules with delocalized pi-orbitals, such as
conjugated polyenes. It is difficult to quantify this interfacial attraction, so
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calculations have been performed for a range of plausible values (kBT 
u 	 0).
Lipid characteristics
The properties of the bilayer depend not only on the characteristics of the
solutes but of the lipid solvent as well. Variation in head group repulsions,
acyl chain unsaturation, and incorporation of cholesterol are all predicted
(Cantor, 1999a) to have a significant effect on the pressure distribution and
on the perturbation of that distribution by solutes. For simplicity, in the
present work, only saturated 16-carbon (palmitoyl) acyl chains are consid-
ered, described by a uniform chain stiffness [(CH2)x]  0.45. However,
effects of varying head group repulsion are considered. It has been shown
(Stigter et al., 1992) that the electrostatic interactions among phosphati-
dylethanolamine (PE) head groups are small and relatively insensitive to
changes in temperature, whereas the repulsions among phosphatidylcholine
(PC) head groups are strong and increase significantly with rising temper-
ature. In the context of a simple mean-field approach (Cantor, 1999a), head
group interactions can be modeled as a pairwise additive energy that varies
inversely with molecular area, with constant of proportionality uhg that is
a measure of the strength of the average repulsion of adjacent head groups.
For pure PC, uhg(PC) is roughly 1 to 1.5 in units of kBT (the value
depending on temperature), and uhg(PE)  0. Note that for a mixture of
head groups, the effective uhg is the average of all pairwise interactions;
thus a 50/50 mix of PC and PE would have uhg  1/4 uhg(PC). Although
it is difficult to estimate the value precisely, the lipid head group compo-
sition of a representative synaptic membrane might be expected to have uhg
of order 0.3 to 0.5kBT; we present results of calculations for uhg  0, 0.4,
and 0.8 kBT to span the range of likely values.
RESULTS
Intrinsic potencies
Alkanes and monohydric alkanols
Fig. 1 a displays predictions of intrinsic potency S as a
function of chain length for semiflexible solutes (  0.45)
with no interfacial attraction of any segment (1  2  . . .
 n 0), as a model of alkanes, and with a large interfacial
attraction of the first segment only (1  10kBT, charac-
teristic of a typical hydrogen bond strength, with 2  3 
. . .  n  0), as a model for strongly amphiphilic solutes
such as 1-alkanols. These results are obtained using a range
of values of the lipid head group pair repulsion energy uhg,
as discussed above. Clearly, for short chains, the attraction
of one end of the molecule to the aqueous interface results
in a much greater potency, i.e., a much greater net shift in
the pressure profile away from the center of the bilayer.
However, with increasing chain length of the amphiphilic
solutes, a marked decrease in intrinsic potency is predicted,
eventually approaching zero (cutoff). The magnitude of the
average lipid head group repulsion is important; at interme-
diate values, a cutoff is predicted at about 12 to 14 carbons.
For solutes without any interfacial attraction, the intrinsic
potency is fairly low for short chains, and in the presence of
lipid head group repulsions, decreases through zero, with a
cutoff at smaller n than for amphiphilic solutes.
The effect of increasing solute stiffness uniformly along
the entire molecule (reducing  from 0.45 to 0.15) is shown
in Fig. 1 b. Unlike the results shown in Fig. 1 a, the decrease
in intrinsic potency is extremely rapid for the amphiphilic
solutes, regardless of lipid head group repulsion, with a
much shorter cutoff predicted at n 
 4 or 5. For longer stiff
amphiphiles, the potency is calculated to be large in mag-
nitude but of opposite sign, i.e., a large negative anesthetic
effect is predicted. For chains without interfacial activity,
the increase in stiffness has a somewhat milder effect on the
shape of the curve, but since S is small even for short chains,
the cutoff is predicted to drop to only 3 or 4 segments.
If the predictions portrayed in Fig. 1, a and b, are accu-
rate, then only the long-chain, stiff amphiphilic molecules,
(large n for solid lines in Fig. 1 b) are predicted to have large
negative intrinsic potencies. These might correspond best to
FIGURE 1 Intrinsic potency, S, as a function of solute chain length, n,
for solutes of the form Cn, i.e., with no interfacial attraction (dotted lines)
and for solutes of the form ACn1, i.e., with strong interfacial attraction for
the first segment only (solid lines). Lines are drawn only as a guide to the
eye. (a) Semiflexible chains (  0.45). (b) Chains with greater (linear)
stiffness (  0.15). Lipid head group repulsion: uhg/kBT  0.0 (■), 0.4
(F), 0.8 (Œ). For ease of comparison, the two panels are plotted using the
same ordinate scale.
2288 Cantor
Biophysical Journal 80(5) 2284–2297
long-chain perfluorinated alkanols; for the choice of param-
eters used (  0.15, and no interfacial activity for any but
the first segment) the effect is not predicted to be of large
magnitude until n 8. The most closely related experimen-
tal work is that of Eger et al. (1999a) on 1-alkanols that are
perfluorinated on all but the hydroxylated carbon (and thus
somewhat less stiff). They find a clear trend with increasing
chain length n from strong intrinsic potency at n  2 to
nonanesthetic at n 7 or 8, qualitatively consistent with the
predictions, although the crossover occurs at somewhat
higher chain length than predicted, which may result from
the fact that the first carbon is hydrogenated. However,
additivity studies were not performed for longer chain
lengths, which according to the predictions of the present
work would be required for negative intrinsic potency to be
observed. It has recently been shown (Ueno et al., 1999) that
unlike the shorter-chain analogues, CF3(CF2)5CH2OH de-
creases the potentiation of GABAA (	-aminobutyric acid)
receptor response to isoflurane (and pentobarbital) ex-
pressed in Xenopus oocytes.
Additivity studies have also been performed (Liu et al.,
1994a) for perfluoroalkanes. The predictions (dashed lines
in Fig. 1 b) indicate that stiff, interfacially inactive mole-
cules show only a mildly negative potency, and then only
for n 
 6 or so. The studies of Liu et al. (1994a) are
inconclusive in that C4F10 and C5F12 do show mild negative
potency, i.e., a 30% increase in MAC of halothane and
isoflurane (but not desflurane), whereas C6F14 shows no
negative potency in additivity studies with isoflurane or
halothane. Liu et al. (1994a) found that only CF4 had
anesthetic potency (using MAC as the anesthetic endpoint),
whereas in earlier studies (Miller et al., 1972) using aboli-
tion of the righting reflex in mice as the endpoint, it was
found that CF4, C2F6, and C3F8 were anesthetics (the C3F8
results were obtained from additivity studies with N2O.)
The results on alkanols described above only consider the
interfacially active (hydroxyl) group on the terminal methyl
segment, corresponding to 1-alkanols. Calculations have
also been performed to predict the effect of varying the
position, labeled j, of the single interfacially active segment
(i.e., the hydroxymethylene group) along the alkanol chain.
(For alkanols, for simplicity of notation, chain segments
with   0, corresponding to -CH2- or -CH3 groups are
labeled C, and those with strong interfacial attraction, such
as -CHOH- or -CH2OH, are labeled A. Thus, alkanes of
length n are symbolized as Cn, 1-alkanols as ACn1, 2-al-
kanols as CACn2, ,-diols as ACn2A, etc.). Fig. 2
shows results for alkanols of two representative chain
lengths, n 9 and n 13, with the hydroxyl at position j
1, 2, . . . , (n  1)/2, i.e., from the terminal methyl group
(ACn1) to the central methylene group (C(n1)/2AC(n1)/2).
For a given n, the intrinsic potency is predicted to be lowest
by far for the 1-alkanols, i.e., for j 1; moving the hydroxyl
toward the middle of the chain is predicted to result in a
sharp increase in potency up to roughly the third segment,
beyond which the potency varies relatively little as the
hydroxyl is moved toward the center of the chain. This
marked increase in potency is to be expected, since a
flexible chain strongly attracted to the aqueous interface at
or near its center should behave similarly to two 1-alkanol
molecules of roughly half the chain length. Because shorter
alkanols have greater intrinsic potency (Fig. 1), and because
there are effectively twice as many molecules, the increase
in potency is large. Although octanol/water and bilayer/
water partition coefficients have been reported for octanols
with hydroxyl group at different positions on the chain
(Hansch and Dunn, 1972; Jain and Wray, 1978), no exper-
imental information is available on their anesthetic poten-
cies, so a comparison to predicted intrinsic potencies is not
yet possible.
Polyhydric alkanols
Predictions have also been obtained for longer hydrocarbon
chains with multiple hydroxyl groups. One group of calcu-
lations involves chains with interfacially active segments
spaced at regular intervals (every L segments) along the
chain between the first and last segments; using the notation
described above, these alkanols can be represented as
(AC2M)yA, with 2M  L  1, and y  (n  1)/L  1, 2,
3, . . . . Such molecules, which are regularly tethered to the
interface, might be expected to behave like 2y short 1-alka-
nol chains, each of effective length n*  M  1. As an
example, (AC4)3A, which corresponds most closely to
FIGURE 2 Intrinsic potency, S, of semiflexible solutes of the form
Cj1ACnj, i.e., with a single segment with strong interfacial attraction A
as a function of the position j of that segment along the chain. This serves
as a model of monohydric alkanols of fixed length but of varied position of
the hydroxyl group along the chain. Results are presented for two chain
lengths: n  9 (■) and n  13 (Œ). All calculations were performed with
head group repulsion uhg/kBT 0.4. Lines are drawn only as a guide to the
eye.
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1,6,11,16-hexadecanetetraol, has values of 2y 6 and n*
3, and thus might be expected to have potency S[(AC4)3A]
 6 S(AC2), where AC2 corresponds most closely to 1-pro-
panol. Using similar reasoning, the results for alkanols with
one hydroxyl group at the center of the chain can be gen-
eralized to oligomers of the form (CMACM)y, where y 
n/L 1, 2, 3, . . . , again defining 2M L 1. Such solutes
might analogously be expected to behave similarly to 2y
short 1-alkanol chains, each of effective length n*  M 
1. As an example, (C3AC3)2, which corresponds most
closely to 4,11-tetradecanediol, has values of 2y  4 and
n*  4, and thus might be expected to exhibit an intrinsic
potency S[(C3AC3)2]  4 S(AC3), where AC3 corresponds
most closely to 1-butanol.
Results for a wide range of such polyhydric alkanols are
presented in Fig. 3 a, in which the potencies S are plotted as
a function of chain length n. Clearly, the potencies are
predicted to get very large compared to even the largest
values for short alkanols. Within a given series of either
type, (CMACM)y or (AC2M)yA, the value of S increases
nearly linearly with the oligomeric repeat index y, consistent
with the above discussion. For given value of y, the intrinsic
potency drops slowly with increasing M, i.e., with increas-
ing separation between interfacially active segments. All of
these results, i.e., for (CMACM)y and for (AC2M)yA with
y 
 1 and thus for 2y  1, can be compared by replotting
them in terms of the intrinsic potency per amphiphilic
subgroup (equivalent short 1-alkanol) i.e., plotting S* 
S/(2y) as a function of n*, as shown in Fig. 3 b. The
similarity of these reduced potencies is evident: all the
predictions from Fig. 3 a fall roughly on a single curve in
Fig. 3 b, similar to (but offset somewhat from) that for
simple 1-alkanols, which is included for purposes of com-
parison. Unfortunately, there is little experimental data on
potency of polyhydric alkanols to which these predictions
can be compared. Moss et al. (1991) measured the potencies
of ,-alkanediols; they observed no cutoff, but studied
only diols of lengths up to n  12. Extrapolation of the
calculated results for ,-alkanediols to S  0 predicts a
cutoff in potency at n  20; it would be interesting to see if
this obtains experimentally. Unfortunately, partition coeffi-
cients have not been reported for the diols for which Moss
et al. obtained aqueous EC50 values, so the prediction of an
approximate doubling of their intrinsic potency can not
presently be tested.
A nearly linear increase in intrinsic potency for oligo-
meric alkanols with increasing number of repeat units is
predicted for all the oligomeric series for which calculations
were performed. In principle, one can imagine that the
hydrophobic/hydrophilic balance can be manipulated by
varying the number of alkyl segments per hydroxyl group,
which will presumably allow for tuning of the oil/water
partition coefficient to an experimentally useful range. In a
first approximation, increasing polymer index in such a
series of molecules would be predicted to maintain an
FIGURE 3 (a) Intrinsic potency, S, as a function of solute chain length,
n, for alkanols of the general form [CMACM]y () and of the form
[AC2M]yA (E), where A corresponds to a strongly interfacially active
segment ( 		 kBT, as a model for -CH2OH or -CHOH- groups) and C
to an interfacially inactive segment (  0, as a model for -CH3 or -CH2-
groups). The lines are drawn to group together solutes of a particular type
and particular values of eitherM or y: solid lines for fixed y and varyingM,
and dashed lines for fixed M and varying y. (b) All results from (a)
re-expressed (‚) as a reduced intrinsic potency S*  S/(2y), i.e., the
intrinsic potency per amphiphilic subgroup, as a function of the number of
segments per subgroup n*  M  1. In both panels, results for solutes of
the form ACn1 (models of 1-alkanols) are provided (F, dotted line). Lipid
head group repulsion uhg/kBT  0.4 in all cases.
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oil/water partition coefficient that is approximately con-
stant, while increasing intrinsic potency roughly linearly,
and thus increasing apparent potency approximately lin-
early, with no limit with respect to chain length, i.e., no
cutoff.
Localized stiffness: unsaturated alkanes
It is interesting to examine the effect of increasing chain
stiffness nonuniformly along the solute chain, as can be
achieved by localized chain unsaturation or atomic substi-
tutions. Molecules that differ with respect to local rigidity
(and if rigid, whether rod-like or bent) but with otherwise
identical characteristics (distribution of segmental interfa-
cial activity) are predicted to have significantly different
effects on the pressure distribution, as shown in Fig. 4 for
the example of five-segment chains with no segmental
interfacial activity. For an otherwise semiflexible (flex 
0.45) chain, an increase in linear rigidity (rod  0.15) at
any one of the segments is predicted to cause a reduction in
intrinsic potency, the effect increasing roughly additively
with the number of sites of increased linear stiffness. By
contrast, a chain with a single rigid bend (bent  1) is
predicted to have significantly increased potency, although
additional stiff bends in the molecule yield smaller incre-
ments in potency.
For hexynes or trans-alkenes, the local stiffness and
increased interfacial activity (as compared to saturated al-
kanes) would be expected to have opposing effects on
intrinsic potency. In Fig. 5 a, predictions of intrinsic po-
tency for six-segment solutes of varying location and degree
of unsaturation are plotted as a function of u, the interfacial
attraction of segments participating in unsaturated bonds.
For purposes of comparison, the predicted potency for hex-
ane {f, f, f, f} is included. In Fig. 5 b, the results of Fig. 5 a
are replotted as a function of mol  2nuu, the interfacial
attraction per molecule. With regard to intrinsic potency, an
increase in segmental interfacial activity can clearly com-
pensate for increased linear stiffness, to a degree that, for
given total stiffness, depends largely on the total molecular
interfacial activity. However, regardless of the value of u,
a greater intrinsic potency is predicted for 1-hexyne, which
is stiff only at one internal segment, than for 2- or 3-hexyne,
which have approximately the same interfacial attraction as
1-hexyne, but two sites of chain stiffness.
Segment distributions
At present, there is no experimental method by which the
lateral pressure profile can be measured. So it would be
valuable to find other, more readily measurable properties,
the changes in which are at least qualitatively related to
changes in the pressure distribution. The depth-dependent
probability distribution of solute segments (z), i.e., the
likelihood of finding a segment of the solute at a given
membrane depth, independent of the location of the seg-
ment along the solute chain, might be expected to serve as
such a property since it can, in principle, be measured, and
is obtained from the statistical mechanical approach used to
calculate the lateral pressure profiles. For small, strongly
interfacially active solutes, such as short 1-alkanols, the
predicted large increase in pressures near the aqueous in-
terface is certainly related to the fact that the segments of
the solute are localized in the region where the pressures
increase, and this is consistent with the difference in spatial
distributions of some anesthetics and nonimmobilizers
(North and Cafiso, 1997; Tang et al., 1997; Chipot et al.,
1997). However, this correlation does not hold in a com-
parison of molecules of similar interfacial activity, but of
different stiffness, as shown by comparison of the results in
Figs. 1 and 6. In Fig. 6 a, plots of (z) are reported over a
range of chain lengths, for solutes Cn, i.e., with no interfa-
cial activity (i  0, i  1, . . . , n) and of the same
flexibility as the lipid acyl chains ( 0.45). For very short
chain solutes, which are predicted to have small positive
intrinsic potencies, the segment probability distribution is
nearly uniform, but with increasing chain length, the distri-
bution becomes strongly skewed toward the center of the
bilayer, consistent with neutron diffraction experiments of
White et al. (1981) on hexane. Comparison of these results
with the chain length dependence of the intrinsic potency,
FIGURE 4 Intrinsic potency, S, of five-segment solutes without interfa-
cial attraction but with nonuniform internal stiffness. The three internal
segments are progressively replaced by stiffer bonds; either rod-like (F,
 0.15; ,  0.0) or rigidly bent (Œ,  1). Results for both one and
two rigid bonds represent, in each case, averages over the different possible
spatial arrangements of the rigid bonds. Results are presented for two
values of the head group repulsion: uhg/kBT  0.0 (solid lines) and
uhg/kBT  0.4 (dashed lines). Lines are drawn only as a guide to the eye.
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one might conclude that potency is lost when the segment
distribution shifts strongly toward the membrane interior.
However, different conclusions are reached when the stiff-
ness of the solute is increased at fixed chain length. In Fig.
6 b, the spatial distribution is plotted as a function of
increasing chain stiffness, for n  8 segment solutes. The
increase in stiffness is predicted to have a small effect on the
probability distribution, if any, causing a shift from the
interior toward the aqueous interface. However, the in-
creased stiffness is predicted to cause a loss in intrinsic
potency, as seen in a comparison of Fig. 1, a and b. Results
for alkanes of other chain lengths are similar.
In Fig. 7 a, the segment probability distribution (z) is
plotted for a range of chain lengths for 1-alkanols (ACn1),
i.e., for semiflexible solutes (  0.45) with one end
attracted to the interface (1  10, i  0, i  2, . . . , n).
Increasing the chain length of semiflexible 1-alkanols is
FIGURE 5 Effect of interfacial activity of unsaturated segments on the
calculated intrinsic potency, S, of six-segment solutes (as models of
hexynes or trans-hexenes). (a) S is plotted as a function of u, the
magnitude of the interfacial attractive energy per unsaturated segment, in
units of kBT. (b) Same data as in (a), but plotted as a function of the
magnitude of the interfacial attractive energy per molecule, mol 
2nuu (in units of kBT) where nu is the number of unsaturated bonds (and
thus 2nu is the number of unsaturated segments) in the molecule. nu  1
(solid lines): 1-hexyne {s, f, f, f}, (▫); 2-hexyne {s, s, f, f}, (E); 3-hexyne
{f, s, s, f}, (). nu  2 (short dashed lines): 1,3-hexadiyne {s, s, s, f}, ();
1,4-hexadiyne {s, f, s, s}, (*); 1,5-hexadiyne {s, f, f, s}, (‚); 2,4-hexadiyne
{s, s, s, s}, (); nu 3 (long dashed line): 1,3,5-hexatriyne {s, s, s, s}, (ƒ).
Predictions for the fully saturated hexane {f, f, f, f}, (F), are included for
purposes of comparison. In the above list, the flexibility of the four interior
bonds are indicated by s (stiff,  0.15) or f (semiflexible,  0.45). For
all calculations, uhg/kBT  0.0.
FIGURE 6 Spatial probability distribution (z) of segments of solutes
with no interfacial activity (i  0, i  1, . . . , n) for varying chain length
(n) and stiffness (). Bilayer depth z(Å) indicates the distance from the
bilayer midplane (in either direction, since the bilayer is symmetric). (a)
Semiflexible chains (  0.45) of length n  1 (), 2 (E), 4 (), 6 (),
10 (‚), and 14 (ƒ). (b) Fixed alkane chain length n  8, for varying chain
stiffness:   0.45 (), 0.30 (E), and 0.15 (‚).
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predicted to cause a marked shift of the segment distribution
toward the bilayer interior, and is accompanied by a more
gradual decrease in intrinsic potency (Fig. 1 a). In Fig. 7 b,
plots of (z) are presented over a range of chain stiffnesses
for alkanols of length n  8. The increase in stiffness at
fixed chain length is predicted to result in a less pronounced
shift in the segment distribution than seen in Fig. 7 a for an
increase in length at fixed stiffness, but is accompanied by
a much greater drop in potency (to very negative values).
Unfortunately, from the results presented in Figs. 6 and 7, it
seems that there is no simple predictive relation between the
intrinsic potency of a solute and the depth distribution of its
segments.
Apparent potencies
The approach described above predicts the chain length
dependence of the intrinsic potency for linear molecules of
varying interfacial activity and stiffness. Although the in-
trinsic potency is a more fundamental measure of potency in
the framework of an indirect mechanism of anesthesia,
apparent potencies are much more commonly used to ex-
press experimental results, so it may be useful to re-express
the predictions in terms of apparent potencies to facilitate
comparison with experiment.
The Meyer-Overton correlation, extended to account for
differences in intrinsic potency, can be expressed as S c*o 
constant, where the oil (bilayer) concentration is given by
c*o Ko/wc*w Ko/gc*g
and thus
c*g  SKo/g1 (2)
for inhalation anesthetics, with a single constant of propor-
tionality (for given bilayer composition). From Eq. 2, the
change in c*g, and thus the change in the apparent potency,
can be determined within a homologous series of com-
pounds that differ only in chain length. For solutes such as
alkanes and many alkane derivatives, Ko/g varies roughly
exponentially with chain length; since n  2 represents the
number of interior segments, then
Ko/g  K0o/gn2 (3)
where K0 is the partition coefficient for solutes with n 
2  0 interior segments, and o/g  1 is the multiplicative
increase in Ko/g per added interior segment. As a rough
guide, o/g  3 for CH2 segments, while for CF2 segments
o/g  2 (Eger et al., 1999a). Within a homologous series,
the gas-phase concentration of an anesthetic with n  2
interior segments, c*g, relative to that of a solute with no
interior segments, c*g(0), is obtained from Eqs. 2 and 3:
log10c*g/c*g0n 2log10o/g log10S/S0 (4)
The analysis leading to Eq. 4 can also be expressed in terms
of aqueous potencies as
log10c*w/c*w0n 2log10o/w log10S/S0
(5)
although for CH2 groups, o/w is somewhat larger than o/g;
of order 3.5 to 4.0. Predictions using Eq. 4 for the depen-
dence of apparent potency on chain length are plotted in Fig.
8 for the same solutes for which calculations of intrinsic
potencies are presented in Fig. 1. Clearly, for alkanes,
alkanols, and perfluorinated alkanols, an increase in appar-
ent potency accompanies a decrease in intrinsic potency
with increasing chain length. These predicted trends are
qualitatively similar to the results summarized recently by
Eger et al. (1999a,b).
DISCUSSION
The results presented here, based on statistical thermody-
namic calculations using a mean-field lattice model to de-
scribe the conformational statistics of acyl chain packing,
FIGURE 7 Spatial probability distribution (z) of segments of 1-al-
kanols (1  10 kBT; i  0, i  2, . . . , n) for varying chain length (n)
and stiffness (). Bilayer depth z(Å) indicates the distance from the bilayer
midplane. (a) Alkanols (semiflexible chains,   0.45) of length n  4
(), 6 (), 10 (‚), and 14 (ƒ). (b) Fixed 1-alkanol chain length n  8, for
varying chain stiffness:   0.45 (), 0.30 (E), and 0.15 (‚).
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demonstrate that the influence of hydrophobic or amphiphi-
lic solutes on the bilayer pressure profile depends sensi-
tively on chain length and particularly on the distribution of
interfacial activity and stiffness over the length of the solute
chain. The large differences in intrinsic potencies among
alkanes, alkanols, and their fluorinated counterparts, includ-
ing the well-known cutoffs in anesthetic potency with in-
creasing chain length, correlate remarkably well with the
predictions of intrinsic potency based on the influence of the
resulting changes in the pressure distribution on protein
conformational equilibria. In particular, the differences in
cutoffs for different types of solute chains are qualitatively
correctly predicted.
Intrinsic potencies are predicted for a range of monohy-
dric and polyhydric alkanols for which potencies have not
yet been measured, but which would serve as an excellent
test of the pressure profile mechanism. Predicted intrinsic
potencies for monohydric alkanols in which the hydroxyl
group is placed on an interior chain segment are predicted to
be much greater than for 1-alkanols of the same length.
Alkanols of length n with a single hydroxyl group near the
middle of the chain are predicted have roughly twice the
potency of 1-alkanols of chain length  n/2; consequently,
the cutoff for such alkanols is predicted to occur at a length
n  20. In general, chains that are regularly tethered to the
aqueous interface, such as polyhydric alkanols with hy-
droxyl groups regularly spaced along the chain, are pre-
dicted to act similarly to a collection of shorter 1-alkanol
chains of length roughly equal to half the spacing between
hydroxyl groups on the chain. The intrinsic potency of such
polyhydric alkanols should thus increase with the number of
repeat units, without limit; certainly no cutoff would be
expected. A measurement of the potencies of such mole-
cules would thus distinguish between indirect and direct
binding mechanisms of anesthesia, since no binding site
could possibly accommodate a molecule without limit in
size, the potency of which only increases with size. Al-
though this argument is made in the context of polyhydric
alkanols, it would be expected to hold for other oligomers
with regularly spaced interfacially active segments, such as
polyethers and polyacids, or if the hydroxyl group is at-
tached to the alkane backbone through a short alkyl spacer.
The predicted sensitivity of pressure redistribution to
increased solute stiffness implies that rod-like, interfacially
inactive molecules should be nonimmobilizers, whether or
not the stiffness is due to perfluorination. However, other
molecular manipulations that cause increased chain linear
rigidity, such as the incorporation of chain unsaturation, will
likely be accompanied by increased interfacial activity,
which has the opposite effect on the pressure distribution.
Unfortunately, an approximate measure of the strength of
the interfacial activity (such as approximate Lennard-Jones
parameters for united-atom carbons involved in multiple
bonds) is not presently available, so a simple comparison of
the intrinsic potencies of alkanes and alkynes, for example,
will not yet serve as a test of this mechanism. Still, mole-
cules having the same total unsaturation (and thus the same
interfacial attraction) but with different degrees of internal
stiffness are clearly predicted to have different potency. For
example, chain molecules with unsaturation located at the
terminal methyl groups are more flexible, and thus should
have higher intrinsic potency, than those with the same
degree of unsaturation located at interior bonds. Thus,
1-hexyne is predicted to have higher intrinsic potency than
2- or 3-hexyne.
On the plausibility of indirect (bilayer-mediated)
mechanisms of anesthesia
It has been suggested by various authors (Franks and Lieb,
1994; Krasowski and Harrison, 1999) that in light of much
of the research on anesthetic mechanisms over the past few
decades, it is very unlikely that anesthesia proceeds by any
indirect, lipid-mediated mechanism. Three classes of argu-
ments are presented. The first concern is the anomalous lack
of potency of some membrane-soluble molecules, i.e., the
significant deviations from the Meyer-Overton correlation.
The results presented here demonstrate that the anomalously
low potency of some membrane-soluble compounds not
only can be rationalized, but is in fact predicted (as is the
anomalously high potency of other compounds) in the con-
FIGURE 8 Predicted gas-phase apparent potency c*g of solutes of length
n (with n  2 interior segments) relative to the predicted apparent potency
c*g(0) of a solute of the same type but of length n  2 (i.e., with no interior
segments) as a function of (n  2), the number of interior segments. The
data are calculated using the approximate relation of Eq. 4, i.e., as log[c*g/
c*g(0)], using intrinsic potencies calculated for uhg/kBT  0.4. Results are
presented for models of 1-alkanols [  0.45; 1  10kBT; i  0, i 
2, . . . , n; o/g  3.0, (F)], perfluorinated alkanols [  0.15; 1 
10kBT; i  0, i  2, . . . , n; o/g  2.0, ()], alkanes [  0.45; i 
0, i 1, . . . , n; o/g 3.0, ()], and perfluorinated alkanes [ 0.15; i
0, i  1, . . . , n; o/g  2.0, (Œ)].
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text of an indirect mechanism based on the lateral pressure
distribution.
A second argument involves the magnitude of the effects
of anesthetics on bilayer properties at clinically relevant
concentrations of anesthetics. It is often noted that the more
readily measured bilayer properties (thickness, fluidity, etc.)
are only slightly altered by incorporation of anesthetics, and
that the changes in these properties can be reproduced by a
slight increase in temperature, which certainly does not
cause anesthesia; on the contrary, a decrease in body tem-
perature can mimic anesthetic effects. The redistribution of
lateral pressures is a remarkable counter-example, in terms
of both the likely magnitude of the effect on protein equi-
libria and the effect of temperature. As discussed in detail
elsewhere (Cantor, 1999a,b), the presence of two lipid/
water interfaces, each of which results in a large interfacial
tension, requires balancing (positive) lateral forces in the
membrane interior, which, being concentrated over a few
nanometers, results in lateral pressure densities in the mem-
brane interior that are of enormous magnitude (many hun-
dreds of atmospheres). Thus, a relatively small redistribu-
tion of these extremely large stresses is predicted to be
sufficient to induce a significant shift in protein conforma-
tional equilibria. The addition of a solute causes a depth-
dependent redistribution of pressures, largely resulting from
the nonuniform spatial and orientational distribution of the
solute in the bilayer, whereas a change in temperature is
likely to result in a small and relatively uniform shift in the
pressure distribution. For example, a drop in temperature
results in a decrease in the repulsions among phosphatidyl-
choline head groups (Stigter et al., 1992), causing a com-
pensating increase in lateral pressures spread through the
bilayer interior, but not a sharp redistribution within the
interior. As mentioned in the Introduction, the increase in
apparent potencies (when measured through gas-phase con-
centrations) with decreasing temperature of most inhalation
anesthetics results largely from an increase in oil/gas parti-
tion coefficients (Franks and Lieb, 1982), leaving the clin-
ically relevant membrane concentration relatively indepen-
dent of temperature, consistent with the predictions based
on the lateral pressure profile mechanism.
The third argument involves stereoselectivity, i.e., the
differential potency demonstrated by enantiomeric pairs,
such as the mild difference between the enantiomers of
isoflurane, and much larger differences in some larger in-
travenous anesthetics. Given that the lipids that comprise
the bilayer are enantiomerically pure, with a chiral center
located in the glycerol moiety, it is likely that the local
interactions between the anesthetic and the lipid will differ
for the two enantiomers of the anesthetic; altered local
packing could certainly result in differential effects on the
stress distribution, particularly as many anesthetics partition
nonuniformly in the bilayer, with a preference for the region
in which the glycerol linkage between the acyl chains and
head group of the lipids is concentrated. It is important to
note that colligative properties of the bilayer based on
solvent equilibria, such as freezing point depression, would
not be expected to depend on the choice of solute enantio-
mer, even though the lipid “solvent” is enantiomerically
pure. As in bulk systems, colligative properties such as
osmotic pressure, Raoult’s law, and freezing point depres-
sion depend only on the decrease in chemical potential of
the solvent that accompanies addition of a solute impurity
(that is soluble only in the fluid solvent phase), which, at
low concentrations, results purely from an increase in trans-
lational entropy, independent of the identity of the solute.
That the freezing point depression of the main phase tran-
sition in a pure lipid bilayer is identical at the same aqueous
concentrations of the two isomers of isoflurane (Franks and
Lieb, 1991) is evidence that the aqueous/bilayer partition
coefficients of the two enantiomers are identical, but has no
bearing on the plausibility of a lipid-mediated mechanism of
general anesthesia.
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